These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 8261806)

  • 101. Chronic leg ulceration associated with polycythemia vera responding to ruxolitinib (Jakafi(®)).
    Shanmugam VK; McNish S; Shara N; Hubley KJ; Kallakury B; Dunning DM; Attinger CE; Steinberg JS
    J Foot Ankle Surg; 2013; 52(6):781-5. PubMed ID: 23953278
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Hydroxyurea-related ankle ulcers in patients with myeloproliferative disorders: a case report and review of the literature.
    Cox C; Nowicky D; Young R
    Ann Plast Surg; 1997 Nov; 39(5):546-9. PubMed ID: 9374154
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Nail and skin hyperpigmentation associated with hydroxyurea therapy for polycythemia vera.
    Gropper CA; Don PC; Sadjadi MM
    Int J Dermatol; 1993 Oct; 32(10):731-3. PubMed ID: 8225715
    [No Abstract]   [Full Text] [Related]  

  • 104. Successful healing of hydroxyurea-related leg ulcers with topical granulocyte-macrophage colony-stimulating factor.
    Stagno F; Guglielmo P; Consoli U; Fiumara P; Russo M; Giustolisi R
    Blood; 1999 Aug; 94(4):1479-80. PubMed ID: 10484634
    [No Abstract]   [Full Text] [Related]  

  • 105. Hydroxyurea-associated leg ulceration.
    Disla E; D'Eamour L; Cioriou M
    Ann Intern Med; 1998 Aug; 129(3):252-3. PubMed ID: 9696738
    [No Abstract]   [Full Text] [Related]  

  • 106. Replication status in leukocytes of treated and untreated patients with polycythemia vera and essential thrombocytosis.
    Amiel A; Elis A; Maimon O; Ellis M; Herishano Y; Gaber E; Fejgin MD; Lishner M
    Cancer Genet Cytogenet; 2002 Feb; 133(1):34-8. PubMed ID: 11890987
    [TBL] [Abstract][Full Text] [Related]  

  • 107. The cutaneous side-effects of hydroxyurea.
    Young HS; Khan AS; Kendra JR; Coulson IH
    Clin Lab Haematol; 2000 Aug; 22(4):229-32. PubMed ID: 11012636
    [TBL] [Abstract][Full Text] [Related]  

  • 108. An unwanted side effect of hydroxyurea in a patient with idiopathic myelofibrosis.
    Starmans-Kool MJ; Fickers MM; Pannebakker MA
    Ann Hematol; 1995 May; 70(5):279-80. PubMed ID: 7599291
    [TBL] [Abstract][Full Text] [Related]  

  • 109. A patient case highlighting the myriad of cutaneous adverse effects of prolonged use of hydroxyurea.
    Neill B; Ryser T; Neill J; Aires D; Rajpara A
    Dermatol Online J; 2017 Nov; 23(11):. PubMed ID: 29447639
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Hydroxyurea-associated leg ulceration.
    Kennedy BJ
    Ann Intern Med; 1998 Aug; 129(3):252; author reply 252-3. PubMed ID: 9696737
    [No Abstract]   [Full Text] [Related]  

  • 111. Muco-cutaneous changes during long-term therapy with hydroxyurea in chronic myeloid leukaemia.
    Vassallo C; Passamonti F; Merante S; Ardigò M; Nolli G; Mangiacavalli S; Borroni G
    Clin Exp Dermatol; 2001 Mar; 26(2):141-8. PubMed ID: 11298103
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Hydroxyurea-induced hyperpigmentation with iron deposition.
    Lee KP; Vangipuram RK; Klimas NK; Sanyal S; Koshelev MV
    Dermatol Online J; 2019 Oct; 25(10):. PubMed ID: 31735009
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Cutaneous extramedullary hematopoiesis presenting as leg ulcers.
    Kuo T
    J Am Acad Dermatol; 1981 May; 4(5):592-6. PubMed ID: 7240468
    [TBL] [Abstract][Full Text] [Related]  

  • 114. [MALLEOLAR ULCERS ASSOCIATED TO HYDROXYUREA TREATMENT].
    Aparicio Julián MA; Mayorga Baca MS; Morató García C; Masa Font R; Sánchez Schmidt JM
    Rev Enferm; 2016 Apr; 39(4):42-4. PubMed ID: 27349062
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Oral ulcers caused by hydroxyurea.
    Paleri V; Lindsey L
    J Laryngol Otol; 2000 Dec; 114(12):976-7. PubMed ID: 11177373
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Dermatomyositis-like eruption and leg ulceration caused by hydroxyurea in a patient with psoriasis.
    Kirby B; Gibson LE; Rogers S; Pittelkow M
    Clin Exp Dermatol; 2000 May; 25(3):256-7. PubMed ID: 10844510
    [No Abstract]   [Full Text] [Related]  

  • 117. [Hyperalgesic malleolar ulcer: recovery on the withdrawal of hydroxyurea].
    Liebschutz S; Quéré I; Lukasik E; Dereure O; Rondes J; Janbon C
    Rev Med Interne; 1998 May; 19(5):360-1. PubMed ID: 9775174
    [No Abstract]   [Full Text] [Related]  

  • 118. A Hydroxyurea-induced Leg Ulcer.
    Hwang SW; Hong SK; Kim SH; Seo JK; Lee D; Sung HS
    Ann Dermatol; 2009 Feb; 21(1):39-41. PubMed ID: 20548853
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Hydroxyurea-induced dermatomyositis koebnerizing at the site of previous shingles.
    Veraitch O; Curto-Garcia N; Harrison C; Stefanato CM; McGibbon D
    Clin Exp Dermatol; 2019 Jul; 44(5):546-548. PubMed ID: 30411394
    [No Abstract]   [Full Text] [Related]  

  • 120. Bullet 'manicure': does lead prevent hydroxyurea-induced cutaneous toxicity?
    Falchi L; Quintás-Cardama A
    Jpn J Clin Oncol; 2014 May; 44(5):512. PubMed ID: 24782486
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.